NCT04652921View on ClinicalTrials.gov

Creatine-Guanidinoacetic Acid Supplementation for Sarcopenia (CREGAAS)

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 15, 2020

Primary Completion Date

December 15, 2021

Study Completion Date

December 31, 2021

Conditions
Sarcopenia
Interventions
DIETARY_SUPPLEMENT

Creatine-guanidinoacetic acid

A dietary supplement provided as powder dissolved in a glass of water

OTHER

Inulin

A dietary supplement provided as powder dissolved in a glass of water

Trial Locations (1)

21000

Applied Bioenergetics Lab at Faculty of Sport and PE, Novi Sad

All Listed Sponsors
lead

University of Novi Sad, Faculty of Sport and Physical Education

OTHER

NCT04652921 - Creatine-Guanidinoacetic Acid Supplementation for Sarcopenia (CREGAAS) | Biotech Hunter | Biotech Hunter